Large and diverse data sets help clinical labs tailor treatments

Novel diagnostic technology enables powerful data intelligence, operational improvements and other enhancements in the lab

Testing for change in PCT levels assists with antibiotic stewardship and risk assessment of lower respiratory tract infections and sepsis

Binding Site’s Immunologicals Group is pleased to announce the introduction of a number of infectious | contagious disease state sera/plasma products to its broad portfolio

The ins and outs of lab-developed tests.

Brian Nahed, MD, talks to contributing editor Tanuja Koppal, PhD, about the need to develop techniques to detect and monitor disease progression

Comprehensive screening of biological samples in forensic and clinical toxicology is not possible without powerful, highly sensitive instruments

According to research firm Market Research Future (Pune, India), the global biomarker test market will reach $16 billion by 2022

Computer modeling and simulation has become a vital part of the drug development process

While HPLC and mass spec make inroads into nontraditional markets, interest remains in molecular techniques that address the unique needs of  clinicians and drug developers.